RxDoctor Payments Data

James Boyes

Physician Assistant · de Soto, KSNPI 1962570713

Payments from drug & device makers

$2,340in general payments, 2019–2025

Across 137 payments — averaging $17.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$558
  • Lilly USA, LLC$402
  • Novo Nordisk$212
  • Pfizer$203
  • AstraZeneca$158
  • Boehringer Ingelheim$150
  • plus $657 from 18 others

What the payments were for

  • Food & beverage$2,340100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,340 in reported general payments places this provider in the 80th percentile of 1,016 physician assistant providers in Kansas.

See all physician assistant providers in Kansas

Medicare billing

Part B allowed, 2024
$32,849
Medicare patients
146
Services billed
789

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin68$56,876
OzempicSemaglutide50$55,717
MounjaroTirzepatide24$32,954
EliquisApixaban23$17,060
FarxigaDapagliflozin Propanediol28$16,472
SymbicortBudesonide/Formoterol Fumarate36$11,741
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen314$9,705
Janumet XrSitagliptin Phos/Metformin Hcl12$6,919
GlyxambiEmpagliflozin/Linagliptin11$6,611
Albuterol Sulfate HfaAlbuterol Sulfate164$4,152
VascepaIcosapent Ethyl11$3,928
Lantus SolostarInsulin Glargine,hum.Rec.Anlog21$3,381
Dexlansoprazole DrDexlansoprazole15$3,364
Omeprazole274$3,339
Methylphenidate ErMethylphenidate Hcl20$3,043

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Glyxambi$150$63,48879 claims
Novo NordiskOzempic$212$55,71750 claims
Lilly USA, LLCMounjaro$402$32,95424 claims
AstraZenecaFarxiga, Symbicort$158$28,21364 claims
PfizerEliquis$203$17,06023 claims
MerckJanumet Xr$76$6,91912 claims
GSKArnuity Ellipta$54$2,94513 claims
AbbVieSynthroid$558$1,51014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,016 physician assistant providers in Kansas.

Other physician assistant in de Soto

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →